Idrx, Inc., A Wholly Owned Subsidiary Of Gsk, Llc

This study is the first time IDRX-42 is being tested in people. It is for adults with advanced GIST (a type of stomach or digestive tract cancer) that has spread or cannot be removed by surgery. The main goals are to check the drug's safety, find the best dose, and see if it can …